Sight Sciences officer proposes $70.6K share sale
The notice says the proposed sale includes shares to cover the tax obligation from settling a vested equity award.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sight Sciences, Inc. (SGHT) reports a proposed sale by David Y. Badawi, identified as an officer and director, of 7,797 common shares, with an approximate sale date of October 1, 2026, through Fidelity Brokerage Services LLC. The notice lists an aggregate market value of $70,555.84. Badawi acquired 7,797 shares through restricted stock vesting on September 30, 2026. The notice says the sale includes an amount necessary to cover the tax obligation resulting from settlement of the vested equity award distribution.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
equity award distribution financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What previous SGHT sales does David Y. Badawi report?
AI-generated analysis. How Rhea-AI works. Not financial advice.